Antibody in Defense Against Neonatal Candida Infections

防御新生儿念珠菌感染的抗体

基本信息

项目摘要

DESCRIPTION (provided by applicant): Candida albicans is an important cause of invasive infections in the premature neonate. Although the neonate is generally considered as an immunocompromised host, the mechanisms of anti-fungal host defense are poorly defined. Specific antibodies have a role in cell mediated resistance to infection. The long range goal of this proposal is to understand the mechanisms by which specific antibodies may augment host resistance to Candida infection in the immunocompromised neonate. These studies should provide the basis for the development of reagents suitable for passive immunization and additional therapies for these serious infections in patients at risk. The principal investigator is in the first year of a faculty appointment in Pediatrics at Brown University. He earned his M.D. and his Ph.D. in microbiology from the University of Rochester and completed his clinical training as a neonatologist. His graduate and fellowship research was focused on mechanisms of microbial pathogenesis from the perspective of the microbe, and his mentors were basic scientists. This proposal addresses antimicrobial mechanisms from the perspective of the neonatal host. The goals of this sponsored award are twofold. The primary aim is to take advantage of the rich research and training environment at Brown University and its connections with the greater New England region to gain experience in immunobiology. This goal will be achieved through coursework, seminars, and direct mentoring of the research plan with successful and established immunologists. The second aim is to gain expertise in the challenges of maturing as a physician-scientist through a close and sustained interaction in a mentored relationship. The structure and personnel included in this proposal will support the candidate in his long term goal of becoming an established scientist focused on the population to whom he has made his clinical commitment as a physician. As such, he will be in an ideal position to orchestrate the translation of basic science to the benefit of patients.
描述(由申请方提供):白色念珠菌是早产儿侵袭性感染的重要原因。虽然新生儿通常被认为是一个免疫功能低下的主机,抗真菌宿主防御机制的定义很差。特异性抗体在细胞介导的抗感染中起作用。这项建议的长期目标是了解特异性抗体可能增强免疫功能低下新生儿对念珠菌感染的宿主抵抗力的机制。这些研究为开发适用于被动免疫的试剂和针对高危患者的这些严重感染的额外治疗提供了基础。首席研究员是在布朗大学儿科教师任命的第一年。他获得了医学博士学位。和他的博士学位。在罗切斯特大学获得微生物学学位,并完成了作为微生物学家的临床培训。他的研究生和奖学金研究主要集中在从微生物的角度来看微生物致病机制,他的导师是基础科学家。该提案从新生儿宿主的角度阐述了抗菌机制。这个奖项的目的是双重的。主要目的是利用布朗大学丰富的研究和培训环境及其与大新英格兰地区的联系,以获得免疫生物学方面的经验。这一目标将通过课程,研讨会和直接指导的研究计划与成功和建立免疫学家实现。第二个目标是通过指导关系中的密切和持续的互动,在作为一名医生-科学家成熟的挑战中获得专业知识。本建议书中包含的结构和人员将支持候选人实现其长期目标,即成为一名成熟的科学家,专注于他作为医生做出临床承诺的人群。因此,他将处于一个理想的位置,协调基础科学的翻译,以造福患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Mark Bliss其他文献

Joseph Mark Bliss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Mark Bliss', 18)}}的其他基金

NEONATAL CANDIDIASIS & IMMUNE COMPROMISE DURING DEVELOPMENT
新生儿念珠菌病
  • 批准号:
    8360538
  • 财政年份:
    2011
  • 资助金额:
    $ 10.26万
  • 项目类别:
NEONATAL CANDIDIASIS & IMMUNE COMPROMISE DURING DEVELOPMENT
新生儿念珠菌病
  • 批准号:
    8168326
  • 财政年份:
    2010
  • 资助金额:
    $ 10.26万
  • 项目类别:
NEONATAL CANDIDIASIS & IMMUNE COMPROMISE DURING DEVELOPMENT
新生儿念珠菌病
  • 批准号:
    7960415
  • 财政年份:
    2009
  • 资助金额:
    $ 10.26万
  • 项目类别:
Antibody in Defense Against Neonatal Candida Infections
防御新生儿念珠菌感染的抗体
  • 批准号:
    6912315
  • 财政年份:
    2005
  • 资助金额:
    $ 10.26万
  • 项目类别:
Antibody in Defense Against Neonatal Candida Infections
防御新生儿念珠菌感染的抗体
  • 批准号:
    7356464
  • 财政年份:
    2005
  • 资助金额:
    $ 10.26万
  • 项目类别:
Antibody in Defense Against Neonatal Candida Infections
防御新生儿念珠菌感染的抗体
  • 批准号:
    7029664
  • 财政年份:
    2005
  • 资助金额:
    $ 10.26万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 10.26万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 10.26万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 10.26万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 10.26万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 10.26万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 10.26万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 10.26万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 10.26万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 10.26万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 10.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了